Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study
Crossref DOI link: https://doi.org/10.1007/s00535-014-0979-2
Published Online: 2014-08-13
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hayashi, Norio
Mobashery, Niloufar
Izumi, Namiki
License valid from 2014-08-13
